Another Case of Rituxan Induced PML

Schmidt & Clark, LLP is No Longer Taking These Cases - If you feel that you may have a potential case, we urge you to contact another law firm adequately suited to handle your case.

On October 23, 2009 the U.S. Food & Drug Administration (FDA) issued an urgent warning to patients and physicians regarding Rituxan. The FDA and the drugs manufacturer have learned of a third case of Rituxan induced progressive multifocal leukoencephalopathy (PML).

Provided below are links to the FDA and manufacturers website(s):

Additional Resources:

Awards & recognition